Law360, New York (December 17, 2013, 4:21 PM EST) -- A South Carolina federal judge ruled Monday that Eli Lilly & Co. did not fail to adequately warn an Iraq War veteran that the antidepressant Cymbalta can cause so-called brain zaps and other withdrawal symptoms, finding that a stronger warning would not have altered his treatment.
U.S. District Judge Cameron McGowan Currie granted summary judgment to Eli Lilly in a lawsuit brought by plaintiff Scott Carnes, who claimed he suffered “sharp, painful zaps of electricity” in his head, nightmares and anger issues after quitting Cymbalta, and...
Eli Lilly Defeats Soldier's Cymbalta 'Brain Zap' Suit
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
